It was previously reported that the UGT2B17 deletion polymorphism was not associated with an increased risk of prostate cancer in African-Americans from Arkansas [13] but was associated with an increased risk (OR = 1.9) in Caucasian subjects from Florida that included 293 cases and a similar number of controls [13]. Here, UGT2B17 is linked to Familial prostate cancer.